Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept with or without methotrexate in active plaque psoriasis despite methotrexate therapy
2004-004201-18Phase 4Completed
- Sponsor
- Wyeth
- Start
- Dec 2004
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of etanercept in plaque psoriasis (2 arms), sponsored by Wyeth. Primary endpoint: Physician's Global Assessment response at 24 weeks. Started Dec 2004; status: completed.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2004-004201-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004201-18.